COPD Trial, Recruiting (NCT06644898)

COPD Trial, Recruiting NCT06644898 Sponsor: Acibadem University Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT06644898 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with COPD, classified in groups A, B, or E according to the GOLD assessment system
People who are able to walk and move around on their own
People who have no medical reasons preventing them from doing exercise

Who may not be able to join:

People whose COPD is rated as GOLD stage 4 based on breathing test results
People who have low oxygen levels in their blood
People who have taken part in a lung rehabilitation program in the last 6 months
People who have had a flare-up or worsening of their COPD in the last month
People who have also been diagnosed with another breathing condition, such as asthma or bronchiectasis
People who have previously had lung surgery
People who have a bone, joint, neurological, or heart condition that affects their ability to exercise
People who have high blood pressure or diabetes that is not well controlled
People who have a cancer diagnosis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90 216 500 4195

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06644898

Sponsor: Acibadem University

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: +90 216 500 4195

More information: https://clinicaltrials.gov/study/NCT06644898

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with COPD, classified in groups A, B, or E according to the GOLD assessment system
People who are able to walk and move around on their own
People who have no medical reasons preventing them from doing exercise

Who may not be able to join:

People whose COPD is rated as GOLD stage 4 based on breathing test results
People who have low oxygen levels in their blood
People who have taken part in a lung rehabilitation program in the last 6 months
People who have had a flare-up or worsening of their COPD in the last month
People who have also been diagnosed with another breathing condition, such as asthma or bronchiectasis
People who have previously had lung surgery
People who have a bone, joint, neurological, or heart condition that affects their ability to exercise
People who have high blood pressure or diabetes that is not well controlled
People who have a cancer diagnosis

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Acibadem University

Registry

ClinicalTrials.gov

Start date

9 April 2025

Est. completion

1 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Postural stability test; Limits of Stability (LOS) Test; Clinical Test of Sensory Integration of Balance (CTSIB)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov